261 related articles for article (PubMed ID: 23325246)
1. Prenatal stress induces schizophrenia-like alterations of serotonin 2A and metabotropic glutamate 2 receptors in the adult offspring: role of maternal immune system.
Holloway T; Moreno JL; Umali A; Rayannavar V; Hodes GE; Russo SJ; González-Maeso J
J Neurosci; 2013 Jan; 33(3):1088-98. PubMed ID: 23325246
[TBL] [Abstract][Full Text] [Related]
2. Maternal lipopolysaccharide treatment differentially affects 5-HT(2A) and mGlu2/3 receptor function in the adult male and female rat offspring.
Wischhof L; Irrsack E; Dietz F; Koch M
Neuropharmacology; 2015 Oct; 97():275-88. PubMed ID: 26051401
[TBL] [Abstract][Full Text] [Related]
3. Activation of mGlu2/3 metabotropic glutamate receptors negatively regulates the stimulation of inositol phospholipid hydrolysis mediated by 5-hydroxytryptamine2A serotonin receptors in the frontal cortex of living mice.
Molinaro G; Traficante A; Riozzi B; Di Menna L; Curto M; Pallottino S; Nicoletti F; Bruno V; Battaglia G
Mol Pharmacol; 2009 Aug; 76(2):379-87. PubMed ID: 19439499
[TBL] [Abstract][Full Text] [Related]
4. Maternal influenza viral infection causes schizophrenia-like alterations of 5-HT₂A and mGlu₂ receptors in the adult offspring.
Moreno JL; Kurita M; Holloway T; López J; Cadagan R; Martínez-Sobrido L; García-Sastre A; González-Maeso J
J Neurosci; 2011 Feb; 31(5):1863-72. PubMed ID: 21289196
[TBL] [Abstract][Full Text] [Related]
5. Repressive epigenetic changes at the mGlu2 promoter in frontal cortex of 5-HT2A knockout mice.
Kurita M; Moreno JL; Holloway T; Kozlenkov A; Mocci G; García-Bea A; Hanks JB; Neve R; Nestler EJ; Russo SJ; González-Maeso J
Mol Pharmacol; 2013 Jun; 83(6):1166-75. PubMed ID: 23508685
[TBL] [Abstract][Full Text] [Related]
6. Identification of three residues essential for 5-hydroxytryptamine 2A-metabotropic glutamate 2 (5-HT2A·mGlu2) receptor heteromerization and its psychoactive behavioral function.
Moreno JL; Muguruza C; Umali A; Mortillo S; Holloway T; Pilar-Cuéllar F; Mocci G; Seto J; Callado LF; Neve RL; Milligan G; Sealfon SC; López-Giménez JF; Meana JJ; Benson DL; González-Maeso J
J Biol Chem; 2012 Dec; 287(53):44301-19. PubMed ID: 23129762
[TBL] [Abstract][Full Text] [Related]
7. Physiological antagonism between 5-hydroxytryptamine(2A) and group II metabotropic glutamate receptors in prefrontal cortex.
Marek GJ; Wright RA; Schoepp DD; Monn JA; Aghajanian GK
J Pharmacol Exp Ther; 2000 Jan; 292(1):76-87. PubMed ID: 10604933
[TBL] [Abstract][Full Text] [Related]
8. Chronic clozapine treatment restrains via HDAC2 the performance of mGlu2 receptor agonism in a rodent model of antipsychotic activity.
de la Fuente Revenga M; Ibi D; Cuddy T; Toneatti R; Kurita M; Ijaz MK; Miles MF; Wolstenholme JT; González-Maeso J
Neuropsychopharmacology; 2019 Jan; 44(2):443-454. PubMed ID: 30038413
[TBL] [Abstract][Full Text] [Related]
9. Chronic treatment with a metabotropic mGlu2/3 receptor agonist diminishes behavioral response to a phenethylamine hallucinogen.
Halberstadt AL; van der Zee JVF; Chatha M; Geyer MA; Powell SB
Psychopharmacology (Berl); 2019 Feb; 236(2):821-830. PubMed ID: 30448990
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological activation of group-II metabotropic glutamate receptors corrects a schizophrenia-like phenotype induced by prenatal stress in mice.
Matrisciano F; Tueting P; Maccari S; Nicoletti F; Guidotti A
Neuropsychopharmacology; 2012 Mar; 37(4):929-38. PubMed ID: 22089319
[TBL] [Abstract][Full Text] [Related]
11. Role of mGlu2 in the 5-HT
Hideshima KS; Hojati A; Saunders JM; On DM; de la Fuente Revenga M; Shin JM; Sánchez-González A; Dunn CM; Pais AB; Pais AC; Miles MF; Wolstenholme JT; González-Maeso J
Psychopharmacology (Berl); 2018 Nov; 235(11):3149-3165. PubMed ID: 30209534
[TBL] [Abstract][Full Text] [Related]
12. Interactive effects of mGlu5 and 5-HT2A receptors on locomotor activity in mice.
Halberstadt AL; Lehmann-Masten VD; Geyer MA; Powell SB
Psychopharmacology (Berl); 2011 May; 215(1):81-92. PubMed ID: 21153406
[TBL] [Abstract][Full Text] [Related]
13. Chronic treatment with LY341495 decreases 5-HT(2A) receptor binding and hallucinogenic effects of LSD in mice.
Moreno JL; Holloway T; Rayannavar V; Sealfon SC; González-Maeso J
Neurosci Lett; 2013 Mar; 536():69-73. PubMed ID: 23333599
[TBL] [Abstract][Full Text] [Related]
14. 5-HT
Murat S; Bigot M; Chapron J; König GM; Kostenis E; Battaglia G; Nicoletti F; Bourinet E; Bockaert J; Marin P; Vandermoere F
Mol Psychiatry; 2019 Nov; 24(11):1610-1626. PubMed ID: 29858599
[TBL] [Abstract][Full Text] [Related]
15. 5-HT(2A) and mGlu2 receptor binding levels are related to differences in impulsive behavior in the Roman Low- (RLA) and High- (RHA) avoidance rat strains.
Klein AB; Ultved L; Adamsen D; Santini MA; Tobeña A; Fernandez-Teruel A; Flores P; Moreno M; Cardona D; Knudsen GM; Aznar S; Mikkelsen JD
Neuroscience; 2014 Mar; 263():36-45. PubMed ID: 24412375
[TBL] [Abstract][Full Text] [Related]
16. Allosteric signaling through an mGlu2 and 5-HT2A heteromeric receptor complex and its potential contribution to schizophrenia.
Moreno JL; Miranda-Azpiazu P; García-Bea A; Younkin J; Cui M; Kozlenkov A; Ben-Ezra A; Voloudakis G; Fakira AK; Baki L; Ge Y; Georgakopoulos A; Morón JA; Milligan G; López-Giménez JF; Robakis NK; Logothetis DE; Meana JJ; González-Maeso J
Sci Signal; 2016 Jan; 9(410):ra5. PubMed ID: 26758213
[TBL] [Abstract][Full Text] [Related]
17. Heterocomplex formation of 5-HT2A-mGlu2 and its relevance for cellular signaling cascades.
Delille HK; Becker JM; Burkhardt S; Bleher B; Terstappen GC; Schmidt M; Meyer AH; Unger L; Marek GJ; Mezler M
Neuropharmacology; 2012 Jun; 62(7):2184-91. PubMed ID: 22300836
[TBL] [Abstract][Full Text] [Related]
18. N-acetylcysteine modulates hallucinogenic 5-HT(2A) receptor agonist-mediated responses: behavioral, molecular, and electrophysiological studies.
Lee MY; Chiang CC; Chiu HY; Chan MH; Chen HH
Neuropharmacology; 2014 Jun; 81():215-23. PubMed ID: 24534112
[TBL] [Abstract][Full Text] [Related]
19. 5-HT
Olivero G; Grilli M; Vergassola M; Bonfiglio T; Padolecchia C; Garrone B; Di Giorgio FP; Tongiani S; Usai C; Marchi M; Pittaluga A
Neuropharmacology; 2018 May; 133():429-439. PubMed ID: 29499271
[TBL] [Abstract][Full Text] [Related]
20. Behavioral evidence for interactions between a hallucinogenic drug and group II metabotropic glutamate receptors.
Gewirtz JC; Marek GJ
Neuropsychopharmacology; 2000 Nov; 23(5):569-76. PubMed ID: 11027922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
